SCHOTT Pharma AG & Co. KGaA Inhaber-Aktien o.N. (XETRA: 1SXP) Stock Analysis & Fundamentals

1SXPSCHOTT Pharma AG & Co. KGaA Inhaber-Aktien o.N.

XETRA · DE · Healthcare · Medical Instruments & Supplies · schott-pharma.com

22.70EUR-0.22%Mkt Cap: 3.72B $P/E: 25.28Today

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a g…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$142.49BUSDP/E 45.6

EssilorLuxottica Société anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$51.10BUSDP/E 32.5

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.90BUSDP/E 45.4

DIM

Sartorius Stedim Biotech S.A.

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

Solventum Corporation

$15.08BUSDP/E 10.8

COO

The Cooper Companies, Inc.

$14.85BUSDP/E 64.5

BAX

Baxter International Inc.

$13.77BUSD

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap3.72B $

Enterprise Value4.00B $

Revenue (TTM)1.11B $

Gross Profit361.37M $

Net Income (TTM)159.19M $

Revenue/Share7.320 USD

Last Price22.70 EUR

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees5.0K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE000A3ENQ51

Valuation

P/E (Trailing)25.28

P/E (Forward)21.05

PEG—

EV/EBITDA14.77

EV/Revenue3.62

P/S3.38

P/B3.42

EPS (TTM)0.90

EPS (Forward)1.08

52W Range

12.6289% of range24.00

52W High24.00 EUR

52W Low12.62 EUR

Profitability

Gross Margin33.71%

Oper. Margin17.36%

EBITDA Margin24.52%

Profit Margin14.85%

ROE16.42%

ROA9.16%

Growth

Revenue Growth10.00%

Earnings Growth-13.30%

Cash Flow & Leverage

Operating CF195.57M $

CapEx (TTM)157.34M $

FCF Margin-1.94%

FCF Yield-0.58%

Net Debt308.02M $

Net Debt/EBITDA1.14

Balance Sheet

Debt/Equity0.09

Current Ratio1.61

Quick Ratio0.74

Book Value/Sh6.670 EUR

Cash/Share0.1670 EUR

Dividends

Fwd Div Rate0.1800 EUR

Trail. Div Rate0.1800 EUR

Div. Yield0.79%

5Y Avg Yield—

Payout Ratio20.00%

Ex-Div DateFeb 4, 2026

Pay Date—

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)22.61 EUR

Upside (mean)-0.4%

Target Range13.00 EUR – 27.00 EUR

€13.00-0.4% to mean€27.00

# Analysts12

Ownership

Shares Out.150.61M

Float34.35M

Insiders77.00%

Institutions19.77%

Technical

SMA 5019.84 (+14.4%)

SMA 20016.50 (+37.5%)

Beta0.98

S&P 52W Chg18.16%

Avg Vol (30d)76.96K

Avg Vol (10d)92.18K

Technical Indicators

RSI (14)65.4

MACD0.7174

MACD Signal0.7971

MACD Hist.-0.0797

BB Upper23.30 EUR

BB Middle21.88 EUR

BB Lower20.45 EUR

BB Width13.07%

ATR (14)0.7935 EUR

Vol Ratio (20d)1.10x